Premier Path Wealth Partners’s Anavex Life Sciences AVXL Stock Holding History

Premier Path Wealth Partners’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,000	Closed	-$25.9K	–	382
2026 Q2	$25.9K	Hold	10,000	–	–	﹤0.01%	400
2026 Q1	$30.7K	Hold	10,000	–	–	﹤0.01%	398
2025 Q4	$35.6K	Hold	10,000	–	–	﹤0.01%	394
2025 Q3	$89K	Hold	10,000	–	–	0.01%	391
2025 Q2	$92.2K	Hold	10,000	–	–	0.01%	386
2025 Q1	$85.8K	Sell	10,000 -2,500	-20%	-$23.6K	0.01%	371
2024 Q4	$134K	Hold	12,500	–	–	0.02%	368
2024 Q3	$71K	Hold	12,500	–	–	0.01%	363
2024 Q2	$52.8K	Hold	12,500	–	–	0.01%	367
2024 Q1	$63.6K	Hold	12,500	–	–	0.01%	342
2023 Q4	$116K	Buy	+12,500	New	+$86.1K	0.03%	331

Other funds holding AVXL

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return

LexAurum Advisors Overland Park, Kansas $893M AUM

Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

BWM

BNC Wealth Management Beaverton, Oregon $436M AUM 37.7% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Premier Path Wealth Partners's AVXL Position: Q3 2026 in Review

Premier Path Wealth Partners sold out of Anavex Life Sciences (AVXL) in Q3 2026, closing a stake of 10,000 shares — an estimated $25.9K sold.

Premier Path Wealth Partners first reported a position in AVXL in Q4 2023 and held it in 11 quarters. The position peaked at $134K in Q4 2024. 19 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

Premier Path Wealth Partners reported no remaining Anavex Life Sciences position as of Q3 2026 after selling out during the quarter.
Premier Path Wealth Partners sold 10,000 Anavex Life Sciences shares in Q3 2026, an estimated $25.9K.
Premier Path Wealth Partners first reported a position in Anavex Life Sciences in Q4 2023 and held it in 11 quarters.
Premier Path Wealth Partners's Anavex Life Sciences position peaked at $134K in Q4 2024.
19 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.